Ki DoQ: using docking based energy scores to develop ligand based model for predicting antibacterials
Open Access
- 11 March 2010
- journal article
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 125
Abstract
Background: Identification of novel drug targets and their inhibitors is a major challenge in the field of drug designing and development. Diaminopimelic acid (DAP) pathway is a unique lysine biosynthetic pathway present in bacteria, however absent in mammals. This pathway is vital for bacteria due to its critical role in cell wall biosynthesis. One of the essential enzymes of this pathway is dihydrodipicolinate synthase (DHDPS), considered to be crucial for the bacterial survival. In view of its importance, the development and prediction of potent inhibitors against DHDPS may be valuable to design effective drugs against bacteria, in general. Results: This paper describes a methodology for predicting novel/potent inhibitors against DHDPS. Here, quantitative structure activity relationship (QSAR) models were trained and tested on experimentally verified 23 enzyme's inhibitors having inhibitory value (K i) in the range of 0.005-22(mM). These inhibitors were docked at the active site of DHDPS (1YXD) using AutoDock software, which resulted in 11 energy-based descriptors. For QSAR modeling, Multiple Linear Regression (MLR) model was engendered using best four energy-based descriptors yielding correlation values R/q 2 of 0.82/0.67 and MAE of 2.43. Additionally, Support Vector Machine (SVM) based model was developed with three crucial descriptors selected using F-stepping remove-one approach, which enhanced the performance by attaining R/q 2 values of 0.93/0.80 and MAE of 1.89. To validate the performance of QSAR models, external cross-validation procedure was adopted which accomplished high training/testing correlation values (q 2/r 2) in the range of 0.78-0.83/0.93-0.95. Conclusions: Our results suggests that ligand-receptor binding interactions for DHDPS employing QSAR modeling seems to be a promising approach for prediction of antibacterial agents. To serve the experimentalist to develop novel/potent inhibitors, a webserver "Ki DoQ" has been developed http://crdd.osdd.net/raghava/kidoq, which allows the prediction of K i value of a new ligand molecule against DHDPS.Keywords
This publication has 36 references indexed in Scilit:
- Purification, crystallization and preliminary X-ray diffraction studies to near-atomic resolution of dihydrodipicolinate synthase from methicillin-resistantStaphylococcus aureusActa Crystallographica Section F Structural Biology and Crystallization Communications, 2008
- Support vector machine for SAR/QSAR of phenethyl-aminesActa Pharmacologica Sinica, 2007
- Similarity-based virtual screening using 2D fingerprintsDrug Discovery Today, 2006
- Dihydrodipicolinate synthase from Thermotoga maritimaBiochemical Journal, 2006
- Improving QSAR models for the biological activity of HIV Reverse Transcriptase inhibitors: Aspects of outlier detection and uninformative variable eliminationTalanta, 2005
- Crystal structure of dihydrodipicolinate synthase (BA3935) from Bacillus anthracis at 1.94 Å resolutionProteins: Structure, Function, and Bioinformatics, 2005
- Two new irreversible inhibitors of dihydrodipicolinate synthase: diethyl (E,E)-4-oxo-2,5-heptadienedioate and diethyl (E)-4-oxo-2-heptenedioateBioorganic & Medicinal Chemistry Letters, 2005
- Active Learning with Support Vector Machines in the Drug Discovery ProcessJournal of Chemical Information and Computer Sciences, 2003
- Bacterial Resistance: Origins, Epidemiology, and ImpactClinical Infectious Diseases, 2003
- The Crystal Structure of Dihydrodipicolinate Synthase fromEscherichia coliat 2.5 Å ResolutionJournal of Molecular Biology, 1995